Who
Steven R. Fife
President and CEO
Company insider
Files Form 4 as: President and CEO, Lifevantage; CFO and VP of Finance, Active Power; CFO, Lecg.
In numbers
- Trades disclosed
- 162
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 3 Mar 2008
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $34K8,180 at $4.20 | filing |
| 1 Apr 2026filed 3 Apr 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $34K8,180 at $4.20 | filing |
| 1 Jan 2026filed 5 Jan 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $56K9,169 at $6.16 | filing |
| 1 Jan 2026filed 5 Jan 2026 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $56K9,169 at $6.16 | filing |
| 1 Oct 2025filed 3 Oct 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $78K8,181 at $9.56 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —90,718 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —108,960 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —90,718 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —108,960 at $0.00 | filing |
| 31 Aug 2025filed 3 Sep 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $1.3M98,177 at $13.10 | filing |
| 26 Aug 2025filed 28 Aug 2025 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code A | —72,289 at $0.00 | filing |
| 26 Aug 2025filed 28 Aug 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | —48,193 at $0.00 | filing |
| 1 Jul 2025filed 3 Jul 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $282K21,064 at $13.39 | filing |
| 1 Apr 2025filed 3 Apr 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $333K21,089 at $15.79 | filing |
| 1 Jan 2025filed 3 Jan 2025 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $403K22,982 at $17.53 | filing |
| 6 Nov 2024filed 8 Nov 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $539K38,661 at $13.94 | filing |
| 1 Oct 2024filed 3 Oct 2024 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,233 at $0.00 | filing |
| 1 Oct 2024filed 3 Oct 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code M | —3,233 at $0.00 | filing |
| 1 Oct 2024filed 3 Oct 2024 | LFVN LifevantageBiotechnology | SEC FORM 4 Code F | $73K5,907 at $12.33 | filing |
| 26 Aug 2024filed 28 Aug 2024 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code A | —108,959 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.